Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-17-019783

Controller/Prin Fin&Acct Offic bought 9,265 shares at an average $0.48 ($4,490)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-21 Purchase +2,000 $0.47 $942 2,000 D: show line 1 in the form
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-21 Purchase +3,400 $0.49 $1,649 5,400 D: show line 2 in the form
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-22 Purchase +1,825 $0.49 $894 7,225 D: show line 3 in the form
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-24 Purchase +500 $0.50 $248 7,725 D: show line 4 in the form
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-24 Purchase +515 $0.50 $255 8,240 D: show line 5 in the form
Austin Mark John Controller/Prin Fin&Acct Offic 2017-11-24 Purchase +1,025 $0.49 $502 9,265 D: show line 6 in the form
Open-market purchases · 9,265 sh · avg $0.48 · $4,490
Loading xslF345X03/rdgdoc.xml…